Drug Makers Start 2023 With Price Hikes

Jan 4, 2023 — Jan 4, 2023 The other increases on major medications so far include a 6% increase on Pfizer’s Xeljanz (tofacitinib) for rheumatoid arthritis. The median wholesale acquisition cost (WAC) for brand drugs jumped 5% so far in January, and pharma manufacturers have raised prices on about 450 medications, according to early data from 46brooklyn Research.